{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:16:15Z","timestamp":1793330175760,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.05.063","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T18:28:14Z","timestamp":1661970494000},"page":"486-493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Strategies for persistent retention of macromolecules and nanoparticles in the blood circulation"],"prefix":"10.1016","volume":"350","author":[{"given":"Yoshinobu","family":"Takakura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.05.063_bb0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1399-3011.1979.tb01730.x","article-title":"A lipophilic derivative of neocarzinostatin a polymer conjugation of an antitumor protein antibiotic","volume":"14","author":"Maeda","year":"1979","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-409X(00)00134-4","article-title":"SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy","volume":"46","author":"Maeda","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0015","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1152\/physrev.1983.63.4.1536","article-title":"Cellular aspects of transcapillary exchange","volume":"63","author":"Simionescu","year":"1983","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0020","series-title":"Handbook of Physiology: The Cardiovascular System IV","first-page":"467","article-title":"Exchange of macromolecules across the microcirculation","author":"Taylor","year":"1984"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0025","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0030","series-title":"Microspheres and Drug Therapy: Pharmaceutical, Immunological and Medical Aspects","first-page":"1","article-title":"Structural elements determining transport and exchange processes in the liver","author":"Wisse","year":"1984"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0035","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1023\/A:1016084508097","article-title":"Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution","volume":"13","author":"Takakura","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0040","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.addr.2004.12.003","article-title":"Theoretical considerations involving the pharmacokinetics of plasmid DNA","volume":"57","author":"Nishikawa","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1023\/A:1015886708598","article-title":"Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver","volume":"8","author":"Nishida","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1016248701505","article-title":"The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake","volume":"12","author":"Kawabata","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0378-5173(94)90231-3","article-title":"Pharmacokinetics of succinylated proteins and dextran sulfate in mice: implications for hepatic targeting of protein drugs by direct succinylation via scavenger receptors","volume":"105","author":"Takakura","year":"1994","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0060","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS","volume":"6","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0065","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1158\/0008-5472.CAN-12-4561","article-title":"Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology","volume":"73","author":"Prabhakar","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jconrel.2014.03.057","article-title":"EPR: evidence and fallacy","volume":"190","author":"Nichols","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"EPR effect fails in the clinic, what is the future of nanomedicine?","volume":"244","author":"Danhier","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0080","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2019.05.044","article-title":"The beginning of the end of the nanomedicine hype","volume":"305","author":"Park","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2020.07.003","article-title":"Cancer stromal targeting therapy to overcome the pitfall of EPR effect","volume":"154\u2013155","author":"Matsumura","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-021-00470-8","article-title":"Unlocking the potential of antibody-drug conjugates for cancer therapy","volume":"18","author":"Drago","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0100","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1111\/cas.14983","article-title":"Barriers to antibody therapy in solid tumors, and their solutions","volume":"112","author":"Matsumura","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0105","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s40262-019-00789-7","article-title":"Immune checkpoint inhibitors in melanoma: a review of pharmacokinetics and exposure-response relationships","volume":"58","author":"Leven","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0110","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00280-011-1817-3","article-title":"Clinical pharmacology of trastuzumab emtansine (T-DM1): an antibody-drug conjugate in development for the treatment of HER2-positive cancer","volume":"69","author":"Girish","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2217\/imt-2019-0118","article-title":"Eploiting antibody biology for the treatment of cancer","volume":"12","author":"Khanna","year":"2020","journal-title":"Immunotherapy."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijbiomac.2021.07.080","article-title":"The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy","volume":"187","author":"Tao","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0125","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jconrel.2020.10.030","article-title":"Serum protein-based nanoparticles for cancer diagnosis and treatment","volume":"329","author":"Iqbal","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0130","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/acs.molpharmaceut.1c00046","article-title":"The uniqueness of albumin as a carrier in nanodrug delivery","volume":"18","author":"Spada","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00262-004-0624-7","article-title":"Pharmacokinetics and in vitro and in vivo anti-tumor response of an interleukin-2-human serum albumin fusion protein in mice","volume":"54","author":"Melder","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0140","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejca.2021.08.025","article-title":"How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic review","volume":"157","author":"Brigitha","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/10826068.2020.1839907","article-title":"Challenges and advancements in the pharmacokinetic enhancement of therapeutic proteins","volume":"51","author":"Khodabakhsh","year":"2021","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0150","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0006-291X(75)80433-5","article-title":"The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs","volume":"63","author":"Juliano","year":"1975","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2020.105036","article-title":"Role of stealth lipids in nanomedicine-based drug carriers","volume":"235","author":"Rastogi","year":"2021","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0160","first-page":"987","article-title":"Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes","volume":"54","author":"Gabizon","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.598175","article-title":"Rationale and application of PEGylated lipid-based system for advanced target delivery of siRNA","volume":"11","author":"Ge","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0170","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"mRNA vaccine for cancer immunotherapy","volume":"20","author":"Miao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12 months of COVID-19: a timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0185","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1111\/all.14794","article-title":"Allergenic components of the mRNA-1273 vaccine for COVID-19: possible involvement of polyethylene glycol and IgG-mediated complement activation","volume":"76","author":"Klimek","year":"2021","journal-title":"Allergy."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0190","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jaci.2021.04.002","article-title":"Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines","volume":"147","author":"Risma","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.02.016","article-title":"Polymeric micelles in cancer therapy: state of the art","volume":"332","author":"Ghosh","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0200","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.ymthe.2017.04.026","article-title":"Nanomaterial-enabled cancer therapy","volume":"25","author":"Quader","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0205","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0210","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/acs.biomac.8b00546","article-title":"Small delivery vehicles of siRNA for enhanced cancer targeting","volume":"19","author":"Kim","year":"2018","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jconrel.2016.08.041","article-title":"Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles","volume":"244","author":"Yi","year":"2016","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/nyas.13469","article-title":"Exosomes: biology, therapeutic potential, and emerging role in musculoskeletal repair and regeneration","volume":"1410","author":"Cobelli","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0230","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International society for extracellular vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell Vesicles."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0235","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0240","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2013.08.014","article-title":"Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles","volume":"172","author":"Kooijmans","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbiotec.2013.03.013","article-title":"Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection","volume":"165","author":"Takahashi","year":"2013","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0250","doi-asserted-by":"crossref","first-page":"26238","DOI":"10.3402\/jev.v4.26238","article-title":"Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice","volume":"4","author":"Imai","year":"2015","journal-title":"J. Extracell Vesicles."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0255","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/jps.24251","article-title":"Quantitative analysis of tissue distribution of the B16BL6-derived exosomes using a streptavidin-lactadherin fusion protein and iodine-125-labeled biotin derivative after intravenous injection in mice","volume":"104","author":"Morishita","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0260","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41568-020-00299-w","article-title":"The evolving translational potential of small extracellular vesicles in cancer","volume":"20","author":"M\u00f6ller","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0265","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11095-021-02988-z","article-title":"Recent advancement and technical challenges in developing small extracellular vesicles for Cancer drug delivery","volume":"38","author":"Geng","year":"2021","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0270","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biomaterials.2016.07.003","article-title":"Efficient production and enhanced tumor delivery of engineered extracellular vesicles","volume":"105","author":"Watson","year":"2016","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0275","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.01.009","article-title":"PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time","volume":"224","author":"Kooijmans","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0280","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nano.2017.09.011","article-title":"Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations","volume":"14","author":"Kim","year":"2018","journal-title":"Nanomedicine."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12951-019-0563-2","article-title":"Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer","volume":"18","author":"Liang","year":"2020","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0290","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0295","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99263","article-title":"Generation and testing of clinical-grade exosomes for pancreatic cancer","volume":"3","author":"Mendt","year":"2018","journal-title":"JCI Insight."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0300","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/d41573-020-00220-y","article-title":"Exosome-based candidates move into the clinic","volume":"20","author":"Cully","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0305","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/s41467-019-12321-3","article-title":"CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity","volume":"10","author":"Fu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102839","article-title":"Phosphatidylserine-deficient small extracellular vesicle is a major somatic cell-derived sEV subpopulation in blood","volume":"24","author":"Matsumoto","year":"2021","journal-title":"iScience."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0005-2736(94)90038-8","article-title":"Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes","volume":"1190","author":"Litzinger","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0320","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0005-2736(95)00184-0","article-title":"Liposome clearance from blood: different animal species have different mechanisms","volume":"1240","author":"Liu","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2022.05.063_bb0325","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ijpharm.2005.11.003","article-title":"Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice","volume":"308","author":"Saxena","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0330","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1021\/nl302412f","article-title":"Determining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry","volume":"12","author":"Malfatti","year":"2012","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0335","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/10717540490433895","article-title":"Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery","volume":"11","author":"Paciotti","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.05.063_bb0340","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.1103573108","article-title":"Targeting kidney mesangium by nanoparticles of defined size","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:32:57Z","timestamp":1759163577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922005430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":68,"alternative-id":["S0168365922005430"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.063","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for persistent retention of macromolecules and nanoparticles in the blood circulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}